Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesCardiologypriority health VADs & artificial hearts Coverage …
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Modifiedpriority healthPolicy NO. 91509

    Ventricular Assist Devices & Artificial Hearts

    Customize your policy alerts

    Sign up for priority health Policy NO. 91509 alerts

    Get alerted when Policy NO. 91509 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy defines medical necessity, coverage stance, and coding for ventricular assist devices (VADs) and total artificial hearts (TAH) for Priority Health members, including LVADs, RVADs, percutaneous devices, and TAH used as bridge-to-transplant or destination therapy.

    Policy Summary
    Payerpriority health
    PolicyVentricular Assist Devices & Artificial Hearts
    Policy CodePolicy NO. 91509
    Change TypeMaterial - criteria added for extracorporeal and intracorporeal LVADs
    Effective DateAug 1, 2026
    Last ReviewMay 13, 2026
    Next Review DateMay 13, 2026
    Key ActionSubmit prior authorization demonstrating medical necessity and include an advance care planning assessment with VAD or artificial heart requests.
    SourceLink
    POLICY UPDATE CHANGES

    Insertion of an extracorporeal left ventricular assist device is considered medically necessary when the applicable InterQual® criteria are met.

    Insertion of an intracorporeal left ventricular assist device is considered medically necessary when the applicable InterQual® criteria are met.

    RequiredAdvance care assessment must accompany VAD/TAH requests
    ≤14 daysPercutaneous RVAD authorized duration
    FDA-onlyPercutaneous LVAD coverage
    > $1,000Q0508 prior auth (commercial)
    $500Q0508 prior auth (Medicaid)
    ~40+CPT/HCPCS and related procedure codes listed

    Coverage Criteria for VADs and TAH

    Left Ventricular Assist Devices (LVADs)

    Insertion of LVAD (by type) is considered medically necessary when applicable criteria are met.

    LVAD types: Extracorporeal, intracorporeal, or percutaneous LVAD insertion

    Extracorporeal and intracorporeal insertion are considered medically necessary when the applicable InterQual® criteria are met; percutaneous LVADs are considered medically necessary only for FDA‑approved indications and are experimental/investigational for other indications.

    Percutaneous Right Ventricular Assist Devices (RVADs)

    Percutaneous RVADs considered medically necessary under specified conditions.

    Impella RP/Impella 5.5 criteria: Use for up to 14 days in a child or adult with body surface area (BSA) ≥ 1.5 m2 for treatment of acute right heart failure or decompensation following LVAD implantation, myocardial infarction, heart transplant, or open‑heart surgery.<=14 days; BSA ≥ 1.5 m2
    Policy Summary
    Payerpriority health
    PolicyVentricular Assist Devices & Artificial Hearts
    Policy CodePolicy NO. 91509
    Change TypeMaterial - criteria added for extracorporeal and intracorporeal LVADs
    Effective DateAug 1, 2026
    Last ReviewMay 13, 2026
    Next Review DateMay 13, 2026
    Key ActionSubmit prior authorization demonstrating medical necessity and include an advance care planning assessment with VAD or artificial heart requests.
    SourceLink
    On This Page
    Coverage Criteria for VADs and TAHCPT, HCPCS, and ICD-10 CodesProvider Actions, Prior Authorization, and DocumentationBackgroundDefinitionsPolicy Revision History

    Total Artificial Hearts (TAH)

    Total artificial heart (TAH) coverage depends on intended use.

    Bridge to transplant: An FDA‑approved total artificial heart used as a bridge to transplant is medically necessary for transplant‑eligible members at imminent risk of death (NYHA Class IV) due to biventricular failure who are awaiting heart transplantation.NYHA Class IV; transplant‑eligible; imminent risk of death

    Authorization requests should be submitted on the Solid Organ Transplant prior authorization form.

    Destination therapy: Use of a total artificial heart as permanent/destination therapy may be considered medically necessary in select patients; coverage for clinical trial use is defined in the Priority Health Clinical Trials policy.

    Medically Necessary Indications — InterQual®

    Covered when InterQual® criteria are met.

    Extracorporeal LVAD insertion: Insertion of an extracorporeal left ventricular assist device is considered medically necessary when the applicable InterQual® criteria are met.InterQual® criteria

    See Summary of Changes.

    Intracorporeal LVAD insertion: Insertion of an intracorporeal left ventricular assist device is considered medically necessary when the applicable InterQual® criteria are met.InterQual® criteria

    See Summary of Changes.

    Real-time at-home or remote monitoring of vital signs (for example, INR, blood pressure, weight, temperature, or oxygen saturation) using Bluetooth-enabled or similarly enhanced meters, cuffs, scales, thermometers, pulse oximeters, or like devices is not medically necessary. Priority Health will not reimburse additional costs associated with these enhanced connectivity features over conventional instruments that do not include such enhancements.

    Insertions of percutaneous left ventricular assist devices (e.g., TandemHeart, Impella) are considered medically necessary only for FDA‑approved indications. Use of percutaneous LVADs for indications other than those approved by the FDA is considered experimental and investigational due to insufficient evidence in the peer‑reviewed literature.

    Coverage determinations for experimental, investigational, or unproven treatments are excluded except when an individual case review allows an exception. Requests for individual consideration require prior plan approval and will be reviewed by a Priority Health medical director or clinical pharmacist; exceptions may be considered for terminal illness or chronic, life‑threatening, severely disabling conditions causing serious clinical deterioration.

    Enhanced remote or home vital‑sign monitoring devices (for example, Bluetooth‑enabled meters, cuffs, scales, thermometers, and pulse oximeters) are considered not medically necessary when the enhancement is limited to connectivity or convenience features rather than clinically necessary functionality.

    Aside from the items explicitly listed as not medically necessary (enhanced remote/home vital‑sign monitoring devices) and the investigational status of certain device uses, there are no additional specific not medically necessary items called out in this portion of the policy.

    CPT, HCPCS, and ICD-10 Codes

    Covered CPT Codes (implantation, removal, replacement)CPTCovered
    33927Implantation of a total replacement heart system (artificial heart) with recipient cardiectomy
    33928Removal and replacement of total replacement heart system (artificial heart)
    33929Removal of a total replacement heart system (artificial heart) for heart transplantation (List separately in addition to code for primary procedure)
    33975Insertion of ventricular assist device; extracorporeal, single ventricle
    33976Insertion of ventricular assist device; extracorporeal, biventricular
    33977Removal of ventricular assist device; extracorporeal, single ventricle
    33978Removal of ventricular assist device; extracorporeal, biventricular
    33979Insertion of ventricular assist device, implantable intracorporeal, single ventricle
    33980Removal of ventricular assist device, implantable intracorporeal, single ventricle
    33981Replacement of extracorporeal ventricular assist device, single or biventricular, pump(s), single or each pump
    1–10 of 12
    1/2
    Covered CPT Codes (percutaneous and interrogation)CPTCovered
    33990Insertion of ventricular assist device, percutaneous including radiological supervision and interpretation; arterial access only
    33991Insertion of ventricular assist device, percutaneous including radiological supervision and interpretation; left heart, both arterial and venous access, with transseptal puncture
    33992Removal of percutaneous left ventricular assist device, arterial or arterial and venous cannula(s), at separate and distinct session from insertion
    33993Repositioning of percutaneous right or left ventricular assist device with imaging guidance at separate and distinct session from insertion
    33995Insertion of ventricular assist device, percutaneous, including radiological supervision and interpretation; right heart, venous access only
    33997Removal of percutaneous right heart ventricular assist device, venous cannula, at separate and distinct session from insertion
    93750Interrogation of ventricular assist device (VAD), in person, with physician analysis of device parameters, review of device function, with programming, if performed, and report
    ICD-10 Codes that may support medical necessityICD-10
    I11.0 - I11.9Hypertensive heart disease
    I13.0 - I13.2Hypertensive heart and chronic kidney disease
    I21.01 - I21.A9Acute myocardial infarction
    I22.0 - I22.9Subsequent ST elevation and non-ST elevation myocardial infarction
    I23.0 - I23.8Certain current complications following STEMI and NSTEMI
    I42.0 - I42.9Cardiomyopathy
    I50.1 - I50.9Heart failure
    R57.0Cardiogenic shock
    T82.221A - T82.228SMechanical complication of biological heart valve graft
    T82.512A - T82.512SBreakdown (mechanical) of artificial heart
    1–10 of 14
    1/2
    Covered CPT Codes - Implantation/Removal/Replacement (intracorporeal/extracorporeal)CPTCovered
    33927Implantation of a total replacement heart system (artificial heart) with recipient cardiectomy
    33928Removal and replacement of total replacement heart system (artificial heart)
    33929Removal of a total replacement heart system (artificial heart) for heart transplantation (List separately in addition to code for primary procedure)
    33975Insertion of ventricular assist device; extracorporeal, single ventricle
    33976Insertion of ventricular assist device; extracorporeal, biventricular
    33977Removal of ventricular assist device; extracorporeal, single ventricle
    33978Removal of ventricular assist device; extracorporeal, biventricular
    33979Insertion of ventricular assist device, implantable intracorporeal, single ventricle
    33980Removal of ventricular assist device, implantable intracorporeal, single ventricle
    33981Replacement of extracorporeal ventricular assist device, single or biventricular, pump(s), single or each pump
    1–10 of 12
    1/2
    Covered CPT Codes - Percutaneous insertion/removal/interrogationCPTCovered
    33990Insertion of ventricular assist device, percutaneous including radiological supervision and interpretation; arterial access only
    33991Insertion of ventricular assist device, percutaneous including radiological supervision and interpretation; left heart, both arterial and venous access, with transseptal puncture
    33992Removal of percutaneous left ventricular assist device, arterial or arterial and venous cannula(s), at separate and distinct session from insertion
    33993Repositioning of percutaneous right or left ventricular assist device with imaging guidance at separate and distinct session from insertion
    33995Insertion of ventricular assist device, percutaneous, including radiological supervision and interpretation; right heart, venous access only
    33997Removal of percutaneous right heart ventricular assist device, venous cannula, at separate and distinct session from insertion
    93750Interrogation of ventricular assist device (VAD), in person, with physician analysis of device parameters, review of device function, with programming, if performed, and report
    HCPCS Codes - Replacement devices, supplies & componentsHCPCSCovered
    L8698Miscellaneous component, supply or accessory for use with total artificial heart system
    Q0477Power module patient cable for use with electric or electric/pneumatic ventricular assist device, replacement only
    Q0478Power adapter for use with electric or electric/pneumatic ventricular assist device, vehicle type
    Q0479Power module for use with electric or electric/pneumatic ventricular assist device, replacement only
    Q0480Driver for use with pneumatic ventricular assist device, replacement only
    Q0481Microprocessor control unit for use with electric ventricular assist device, replacement only
    Q0482Microprocessor control unit for use with electric/pneumatic combination ventricular assist device, replacement only
    Q0483Monitor/display module for use with electric ventricular assist device, replacement only
    Q0484Monitor/display module for use with electric or electric/pneumatic ventricular assist device, replacement only
    Q0485Monitor control cable for use with electric ventricular assist device, replacement only
    1–10 of 33
    1/4
    Related proceduresCPT / mixed
    33967Insertion of intra-aortic balloon assist device, percutaneous
    33968Removal of intra-aortic balloon assist device, percutaneous
    33970Insertion of intra-aortic balloon assist device through the femoral artery, open approach
    33971Removal of intra-aortic balloon assist device including repair of femoral artery, with or without graft
    33973Insertion of intra-aortic balloon assist device through the ascending aorta
    33974Removal of intra-aortic balloon assist device from the ascending aorta, including repair of the ascending aorta, with or without graft
    92970Cardioassist-method of circulatory assist; internal
    92971Cardioassist-method of circulatory assist; external
    inv-17: BSA for Impella RP/5.5 — body surface area threshold
    BSA thresholdBSA ≥ 1.5 m2
    Applicable devicesImpella RP and Impella 5.5 with SmartAssist
    Indication durationUp to 14 days of support
    inv-18: Q0508 prior authorization threshold — charge thresholds for commercial and Medicaid
    Commercial prior authorization thresholdCharges exceed $1,000
    Medicaid prior authorization thresholdCharges exceed $500
    HCPCS code referencedQ0508 — Miscellaneous supply or accessory for implanted VAD (Prior Authorization required)

    Provider Actions, Prior Authorization, and Documentation

    Prior Authorization

    Prior Authorization Required for Implantation and Related Services

    Prior authorization is required for implantation procedures and related services unless otherwise specified. Providers must obtain prior authorization prior to scheduling implantations (e.g., intracorporeal VAD insertion, total artificial heart implantation) and related services except for removal or repositioning when performed as a separate service, or for interrogation services which do not require prior authorization.

    • Applies to implantable VADs and total artificial hearts listed under CPT codes in this policy.
    • Exemption: removal/repositioning performed as a separate service and interrogation services do not require prior authorization.
    Prior Authorization

    Prior Authorization for Miscellaneous Implanted VAD Supplies (Q0508)

    HCPCS Q0508 (miscellaneous supply or accessory for use with an implanted ventricular assist device) requires prior authorization. Prior authorization is required when charges for replacement device, supplies, and components exceed $1,000 for commercial members and $500 for Medicaid members. Note that device and all supplies for the initial unit are included in the inpatient (IP) stay.

    • Q0508 — Miscellaneous supply or accessory for use with an implanted VAD: Prior authorization required.
    • Prior auth threshold: > $1,000 (commercial), > $500 (Medicaid).
    • Initial device and supplies included in the inpatient stay; do not bill separately for initial unit when included in IP stay.
    Documentation Required

    Advance Care Planning Assessment Required

    Providers must include an advance care planning assessment with requests for VAD or total artificial heart (TAH) services. The assessment must be completed by a qualified provider and should accompany the authorization request.

    • Assessment required for members receiving VADs or artificial hearts (pre- or post-operative).
    • Use Appendix A template as applicable and include with prior authorization submission.
    Prior Authorization

    TAH Authorization Form

    Requests for total artificial heart (TAH) as bridge-to-transplant should be submitted using the Solid Organ Transplant prior authorization form.

    • Use the Solid Organ Transplant prior authorization form for TAH bridge-to-transplant requests.
    Documentation Required

    Medical Necessity Documentation and Individual Case Review

    Providers must submit documentation demonstrating medical necessity for all prior authorization requests. Individual case review may allow coverage of investigational treatments in select circumstances (e.g., terminal illness or severe, progressive disease causing serious clinical deterioration); such requests require prior plan approval and review by a Priority Health medical director or clinical pharmacist.

    • Submit clinical records, diagnostic tests, InterQual® criteria if applicable, and advance care planning assessment to support medical necessity.
    • Requests for investigational or unproven treatments require prior approval and will be reviewed on an individual case basis.
    Note

    Benefit and Eligibility Verification

    Coverage is subject to the member's specific benefits and any applicable group-specific policy. Eligibility and benefit determinations will be made based on the member's plan in effect on the date services are rendered.

    • Verify member eligibility and benefits prior to requesting authorization.
    • Group-specific plan provisions may supersede this medical policy.
    Denial Risk

    Prior Authorization and Investigational Treatments — Denial Risk

    Failure to obtain required prior authorization may result in denial of payment. Prior authorization is also required for requests seeking coverage of investigational treatments; failure to obtain plan approval for investigational or unproven therapies may result in noncoverage.

    • Obtain prior authorization before rendering services that require it to avoid claim denials.
    • Requests for investigational treatments require prior plan approval.

    Background

    Ventricular assist devices (VADs) and total artificial hearts (TAH) provide mechanical circulatory support for patients with severe cardiac dysfunction. These devices may be used as a bridge to transplant for patients awaiting heart transplantation, as temporary support for cardiac recovery in reversible dysfunction, or as destination (permanent) therapy for select patients with end‑stage heart failure not eligible for transplant. LVADs assist the left ventricle, RVADs assist the right ventricle, and TAHs replace both ventricles. Management of patients with VADs or TAH requires a coordinated, multidisciplinary program with experienced clinicians and appropriate institutional capabilities.

    Definitions

    inv-30: Ventricular assist device (VAD) definition — pump, control system, energy supply assisting native heart chambers
    DefinitionA ventricular assist device (VAD) consists of a pump, a control system, and an energy supply used to assist native heart chambers without removing the native heart
    FunctionUsed to assist the left ventricle (LVAD), right ventricle (RVAD), or both as auxiliary or parallel pumps
    Clinical roleProvides circulatory support for transplant candidates, facilitates cardiac recovery, or serves as destination therapy in select patients
    inv-31: Total artificial heart (TAH) definition — implantable pneumatic biventricular support device used as total replacement
    DefinitionA total artificial heart (TAH) is an implantable, pneumatic, biventricular support device that serves as a total replacement for both ventricles
    Primary historical useUsed as a bridge to transplant in patients at imminent risk of death from biventricular failure
    Contemporary useAlso developed for destination (permanent) therapy in select patients with irreversible biventricular heart failure
    inv-32: Total replacement heart system (artificial heart) — coding note referencing codes 33927-33929
    Relevant CPT codes33927, 33928, 33929 describe implantation, removal, and removal for transplant of a total replacement heart system (artificial heart)
    Procedure contextCodes apply to total artificial heart system with recipient cardiectomy and removal prior to transplantation
    Coding noteRefer to listed CPT codes when reporting implantation, replacement, or removal of artificial heart systems
    inv-33: Ventricular assist device (VAD) — coding note referencing codes 33975-33983 and 33990-33997 for insertion/removal/replacement/interrogation
    Covered CPT insertion/removal/replacement codes33975-33983 describe insertion, removal, and replacement for extracorporeal and implantable intracorporeal VADs
    Percutaneous and interrogation codes33990-33997 and 93750 describe percutaneous insertion/removal/repositioning and interrogation of VADs
    Reporting guidanceNo prior authorization is required for removal/repositioning when performed as a separate service, or for interrogation services

    Policy Revision History

    05/13/2026policy_changeLatest

    Added material statements that insertion of extracorporeal and intracorporeal left ventricular assist devices (LVADs) is considered medically necessary when applicable InterQual® criteria are met.